Mary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...

The approach, which mimics how the body responds to a virus, could pave the way for a universal cancer vaccine.

The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...

A new data analysis, published in Vaccine has found that women and menstruating people who had one or more mRNA-based ...

What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have found a way to do just that—by tweaking a key molecule in the vaccine’s ...

A fed-batch reaction is harder to design than a batch process because of the need to specify all the variables and quantities.

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis continues the discussion on mRNA and srRNA ...

Indeed, mRNA vaccines designed to treat cancer (among other diseases) “are quite realistic,” says Anna Blakney, an RNA researcher at the University of British Columbia.

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse model study, bringing researchers ...

Researchers from the National Museum of Natural Sciences in Madrid, Spain, digitally reconstructed the ribcages of four ...